Wolfram Syndrome

Wolfram Syndrome

National Organization for Rare Disorders, Inc.

Important

It is possible that the main title of the report Wolfram Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.

Synonyms

  • Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness
  • DIDMOAD

Disorder Subdivisions

  • None

General Discussion

Wolfram syndrome is the inherited association of childhood-onset diabetes mellitus and progressive-onset optic atrophy. All people affected by Wolfram syndrome have juvenile-onset diabetes mellitus and degeneration of the optic nerve (optic atrophy). In addition, about 70 to 75% of those affected develop diabetes insipidus and about two-thirds develop auditory nerve deafness. Another name for the syndrome is DIDMOAD, which refers to diabetes insipidus, diabetes mellitus, optic atrophy, and deafness.

Symptoms

All of those affected by Wolfram syndrome develop insulin-dependent diabetes mellitus. This occurs generally between one month and 16 years of age, with a median age of six years. The starches and sugars (carbohydrates) in the foods we eat are normally processed by digestive juices into glucose that circulates in the blood as a major energy source for body functions. A hormone produced by the pancreas (insulin) regulates the body's use of glucose. In diabetes mellitus, the pancreas does not manufacture the correct amount of insulin needed to metabolize sugar. As a result, the patient needs daily injections of insulin to regulate blood sugar levels. Symptoms of diabetes mellitus may be frequent urination, extreme thirst, constant hunger, weight loss, itching of the skin, changes in vision, slow healing of cuts and bruises, and in children there is a failure to grow and develop normally. (For more information on this disorder choose "diabetes mellitus" as your search term in the Rare Disease Database).



In addition, all of those affected by Wolfram syndrome also develop primary optic atrophy (OA). This is vision failure caused by wasting away of the nerves that conduct visual stimuli to the brain (optic nerve). Optic atrophy typically becomes apparent with loss of color vision and reduced visual acuity at around 10 years, although the range of ages at which this occurs is from one month to 19 years. Over a period of about eigght years, this condition progresses to perception of only light and dark.



Some people (about 70 to 75%) who have Wolfram syndrome also develop diabetes insipidus. This is not related to diabetes or insulin. The only thing it has in common with diabetes are the symptoms of excessive thirst and urination. This condition results in excretion of large quantities of very dilute urine. Excessive thirst is another major symptom of this disorder. Patients tend to drink enormous quantities of fluid, and they urinate very often. Other symptoms may be dehydration, weakness, dryness of the mouth and skin, and constipation that may develop rapidly if the loss of fluid is not continuously replaced. (For more information on this disorder choose "diabetes insipidus" as your search term in the Rare Disease Database).



Deafness is the fourth major symptom of Wolfram syndrome. About 66% of patients with WS will become deaf. The hearing loss may occur at any time, and may be partial or complete. In some patients the hearing loss may be due to a loss of sense perception transmitted by nerves (sensorineural). Other symptoms may be severe hearing loss, loss of sound intensity or pitch, or loss of the ability to hear high tones.



Some (but not all) of the following additional symptoms may be present in patients with Wolfram syndrome:



Urinary tract abnormalities occur in about two-thirds of patients with WS.



Neurological symptoms such as an awkward way of walking (ataxia) and an exaggerated startle response (myoclonus) affect about 60% of those diagnosed with WS.



Megaloblastic anemia is a blood disorder in which there are large, abnormal, immature red blood cells (megaloblasts). The main symptoms of this disorder are diarrhea, vomiting, lack of appetite (anorexia), and weight loss. Lesions in the gastrointestinal tract may cause difficulty with the absorption of food. Enlargement of the liver and spleen may also occur along with yellow discoloration of the skin (jaundice). (For more information on this disorder choose "Megaloblastic Anemia" as your search term in the Rare Disease Database).



Sideroblastic anemia refers to a group of blood disorders that are characterized by an impaired ability of the bone marrow to produce normal red blood cells. Abnormal red blood cells called sideroblasts can be found in the blood. The main symptoms of this disorder are weakness, fatigue and difficulty breathing. (For more information on this disorder choose "Sideroblastic Anemia" as your search tern in the Rare Disease Database).



Neutropenia may also be present in Wolfram syndrome. Neutropenia is a blood disorder in which the bone marrow does not produce white blood cells containing granules called "neutrophils". This disorder often makes the patient more susceptible to infections from fungus and bacteria. Fever, infection and an enlarged spleen may be present. (For more information on this disorder choose "Neutropenia" as your search term in the Rare Disease Database).



Thrombocytopenia is a disorder in which there are an abnormally small number of platelets in the circulating blood. These platelets are the part of the blood that helps in clotting. Major symptoms of thrombocytopenia may be excessive bleeding in the skin or mucous membranes, sudden nosebleeds and easy bruising. (For more information on this disorder choose "Essential Thrombocytopenia" as your search term in the Rare Disease Database).



Diabetic retinopathy is a disorder of the light sensitive tissue of the eye (retina) caused by diabetes. Unchecked it may lead to visual impairment or blindness. (For more information on this disorder choose "Diabetic Retinopathy" as your search term in the Rare Disease Database).



Psychiatric and behavioral problems such as acute depression, psychosis, and impulsive verbal and physical aggression affect over 50% of patients with confirmed WS.

Causes

Wolfram syndrome is caused by mutations in the WFS1 gene and is inherited as an autosomal recessive trait. For some time, it was thought that one form of Wolfram syndrome might be caused by changes in the DNA found in the mitochondria of cells. Now, the syndrome is generally thought to be associated with changes in one or more genes on chromosome 4 (4p16.1).



Genetic diseases are determined by the combination of genes for a particular trait that are on the chromosomes received from the father and the mother.



Chromosomes, which are present in the nucleus of human cells, carry the genetic information for each individual. Human body cells normally have 46 chromosomes. Pairs of human chromosomes are numbered from 1 through 22 and the sex chromosomes are designated X and Y. Males have one X and one Y chromosome and females have two X chromosomes. Each chromosome has a short arm designated "p" and a long arm designated "q". Chromosomes are further sub-divided into many bands that are numbered. For example, "chromosome 4p16.1" refers to band 16.1 on the short arm of chromosome 4. The numbered bands specify the location of the thousands of genes that are present on each chromosome.



Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.



All individuals carry a few abnormal genes. Parents who are close relatives (consanguineous) have a higher chance than unrelated parents to both carry the same abnormal gene, which increases the risk to have children with a recessive genetic disorder.

Affected Populations

Diabetes mellitus (DM), as a part of the DIDMOAD set of symptoms, affects children as young as five or six years old, although onset in some cases may not occur until the middle or late teens. Optical atrophy will usually be obvious by age nine or ten but in some cases may be deferred to the middle or late teens. In Wolfram syndrome, both of these symptoms typically will have appeared by 14-15 years of age.



Wolfram syndrome affects males and females in equal numbers.

Standard Therapies

Diagnosis

Wolfram syndrome is difficult to diagnose. In many instances, people with this disorder and their doctors may be unaware that the various symptoms and complaints are related and indicate a specific disorder. Initially, the focus may be on one symptom, typically diabetes mellitus, and its treatment. Later, the presence of other symptoms may become apparent.



Treatment

Treatment of Wolfram syndrome is symptomatic and supportive. It will require a multidisciplinary effort to manage the various aspects of this condition. Almost all patients require replacement insulin. Cranial diabetes insipidus responds to intranasal or oral vasopressin. Approximately 25% of patients with hearing impairment benefit from hearing aids.



Genetic counseling may be of benefit for Wolfram syndrome patients and their families.

Investigational Therapies

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.



Individuals and families affected by with Wolfram syndrome should check the U.S. government clinical trials web site (www.clinicaltrials.gov) by searching separately for trials involving each of the major symptoms: diabetes insipidus, optical atrophy, diabetes mellitus, and deafness.



For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:



Tollfree: (800) 411-1222

TTY: (866) 411-1010

Email: prpl@cc.nih.gov



For information about clinical trials sponsored by private sources, contact:

www.centerwatch.com

References

TEXTBOOKS

Behrman RE, Kliegman RM, Arvin AM, eds. Nelson Textbook of Pediatrics. 15th ed. W.B. Saunder Company. Philadelphia, PA; 1996:1574.



Wilson JD, Foster DW, eds. Textbook of Endocrinology. 8th ed. W.B. Saunders Company. Philadelphia, PA; 1992:1563.



Sperling MA, ed. Pediatric Endocrinology. 1st ed. W.B. Saunders Company. Philadelphia, PA; 1996:208; 256.



REVIEW ARTICLES

Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med. 2004;82:510-29.



Cryns K, Sivakumaran TA, Van den Ouweland JM, et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat. 2003;22:275-87.



Barrett TG. Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes. Best Pract Res Clin Endocrinol Metab. 2001;15:325-43.



Khanim F, Kirk J, Latif F, et al. WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat. 2001;17:357-67.



Swift M, Swift RG. Psychiatric disorders and mutations at the Wolfram syndrome locus. Biol Psychiatry. 2000;47:787-93.



JOURNAL ARTICLES

Domenech E, Kruyer H, Gomez C, et al. First prenatal diagnosis for wolfram syndrome by molecular analysis of the WFS1 gene. Prenat Diagn. 2004;24:787-89.



Smith CJ, Crock PA, King BR, et al. Phenotype-genotype correlations in a series of wolfram syndrome families. Diabetes Care. 2004;27:2003-09.



Sequeira A, Kim C, Seguin M, et al. Wolfram syndrome and suicide: evidence for a role of WFS1 in suicidal and impulsive behavior. Am J Med Genet B Neuropsychiatr Genet. 2003;119:108-13.



Lesperance MM, Hall JW 3rd, San Agustin TB et al. Mutations in the wolfram syndrome type 1 gene (WSF1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2003;129:411-20.



Al-Till M, Jarrah NS, Ajlouni KM. Ophthalmologic findings in fifteen patients with wolfram syndrome. Eur J Ophthalmol. 2002;12:84-88.



Torres R, Leroy E, Hu X, et al. Mutation screening of the Wolfram syndrome gene in psychiatric patients. Mol Psychiatry. 2001;6:39-43.



FROM THE INTERNET

McKusick VA, ed. Online Mendelian Inheritance In Man (OMIM). The Johns Hopkins University. Wolfram Syndrome. Entry Number; 222300: Last Edit Date; 2/22/2005.



Patient Information Leaflet: Wolfram Syndrome. Worldwide Society of Wolfram Syndrome Families. 7th February, 2000. 3pp.

www.wolframsyndrome.org



Wolfram Syndrome. National Coalition for Health Professional Education in Genetics. (NCHPEG). nd. 2pp.

www.nchpeg.org/cdrom/wolfram.htm



Wolfram Syndrome. Clinical Molecular Genetics Society (CMGS). 11.2.99. 2pp.

www.ich.ucl.ac.uk/cmgs/wolfram.htm



Koenig J. DI : Stories and Articles: Wolfram Syndrome. The Diabetes Insipidus Foundation. 2003. 2pp.

www.diabetesinsipidus.org/4di_wolfram.htm

Resources

March of Dimes Birth Defects Foundation

1275 Mamaroneck Avenue

White Plains, NY 10605

Tel: (914)997-4488

Fax: (914)997-4763

Tel: (888)663-4637

Email: Askus@marchofdimes.com

Internet: http://www.marchofdimes.com



Lighthouse International

111 E 59th St

New York, NY 10022-1202

Tel: (800)829-0500

Email: info@lighthouse.org

Internet: http://www.lighthouse.org



National Association for Parents of Children with Visual Impairments (NAPVI)

P.O. Box 317

Watertown, MA 02272-0317

Tel: (617)972-7441

Fax: (617)972-7444

Tel: (800)562-6265

Email: napvi@perkins.org

Internet: http://www.napvi.org



NIH/National Eye Institute

31 Center Dr

MSC 2510

Bethesda, MD 20892-2510

United States

Tel: (301)496-5248

Fax: (301)402-1065

Email: 2020@nei.nih.gov

Internet: http://www.nei.nih.gov/



NIH/National Heart, Lung and Blood Institute

P.O. Box 30105

Bethesda, MD 20892-0105

Tel: (301)592-8573

Fax: (301)251-1223

Email: nhlbiinfo@rover.nhlbi.nih.gov

Internet: http://www.nhlbi.nih.gov/



NIH/National Institute of Diabetes, Digestive & Kidney Diseases

Office of Communications & Public Liaison

Bldg 31, Rm 9A06

31 Center Drive, MSC 2560

Bethesda, MD 20892-2560

Tel: (301)496-3583

Email: NDDIC@info.niddk.nih.gov

Internet: http://www2.niddk.nih.gov/



Genetic and Rare Diseases (GARD) Information Center

PO Box 8126

Gaithersburg, MD 20898-8126

Tel: (301)251-4925

Fax: (301)251-4911

Tel: (888)205-2311

TDD: (888)205-3223

Internet: http://rarediseases.info.nih.gov/GARD/



Perkins School for the Blind

175 North Beacon Street

Watertown, MA 02472

Tel: (617)924-3434

Fax: (617)926-2027

Email: Info@Perkins.org

Internet: http://www.Perkins.org



National Consortium on Deaf-Blindness

The Teaching Research Institute

345 N. Monmouth Avenue

Monmouth, OR 97361

Tel: (800)438-9376

Fax: (503)838-8150

Tel: (800)438-9376

TDD: (800)854-7013

Email: info@nationaldb.org

Internet: http://www.nationaldb.org



For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use . How this information was developed to help you make better health decisions.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.